Toll Free: 1-888-928-9744

Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Janssen Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Janssen Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Janssen Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Janssen Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Janssen Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Janssen Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

- Evaluate Janssen Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Janssen Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Janssen Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Janssen Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Janssen Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Janssen Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Janssen Pharmaceuticals, Inc. Snapshot 5
Janssen Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Janssen Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Janssen Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Janssen Pharmaceuticals, Inc. - Pipeline Products Glance 12
Janssen Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Janssen Pharmaceuticals, Inc. - Early Stage Pipeline Products 13
Discovery Products/Combination Treatment Modalities 13
Janssen Pharmaceuticals, Inc. - Drug Profiles 14
JNJ-56914845 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ORM-12741 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
DiTU 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
LCTA-949 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Janssen Pharmaceuticals, Inc. - Pipeline Analysis 19
Janssen Pharmaceuticals, Inc. - Pipeline Products by Target 19
Janssen Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 20
Janssen Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 21
Janssen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 22
Janssen Pharmaceuticals, Inc. - Recent Pipeline Updates 23
Janssen Pharmaceuticals, Inc. - Discontinued Pipeline Products 25
Discontinued Pipeline Product Profiles 25
APD-597 25
Janssen Pharmaceuticals, Inc. - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28
List of Tables
Janssen Pharmaceuticals, Inc., Key Information 5
Janssen Pharmaceuticals, Inc., Key Facts 5
Janssen Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7
Janssen Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8
Janssen Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9
Janssen Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014 10
Janssen Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11
Janssen Pharmaceuticals, Inc. - Phase II, 2014 12
Janssen Pharmaceuticals, Inc. - Discovery, 2014 13
Janssen Pharmaceuticals, Inc. - Pipeline by Target, 2014 19
Janssen Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 20
Janssen Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 21
Janssen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 22
Janssen Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 23
Janssen Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 25
Janssen Pharmaceuticals, Inc., Subsidiaries 26 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify